JPH05304988

PURPOSE:To provide the novel monoclonal antibody useful for immunological therapies, etc., for cancer cells. CONSTITUTION:The HD-resistant human monoclonal IgG antibody uniquely reacting with a HD antigen. The HD antigen includes a HD3 antigen. The HD human monoclonal IgG antibody uniquely reacting...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TANETANI TOSHIYUKI, HIYAMUTA SHUICHI, KADOTA AKIHIKO
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA DIAGNOSIS ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE IDENTIFICATION INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS SURGERY TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PURPOSE:To provide the novel monoclonal antibody useful for immunological therapies, etc., for cancer cells. CONSTITUTION:The HD-resistant human monoclonal IgG antibody uniquely reacting with a HD antigen. The HD antigen includes a HD3 antigen. The HD human monoclonal IgG antibody uniquely reacting with the HD3 antibody is produced from SHHD1 (FERM P-12696).